Literature DB >> 16018838

Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus.

Jie J Cao1, Michael Hudson, Michelle Jankowski, Fred Whitehouse, W Douglas Weaver.   

Abstract

Acute hyperglycemia during myocardial infarction predicts adverse short-term outcomes and mortality in diabetic patients. Conversely, chronic hyperglycemia is associated with an increased incidence of long-term cardiovascular complications, although its effect on acute hyperglycemic response and mortality after acute myocardial infarction is unknown. We investigated the prognostic relation of the glucose concentration at admission and the baseline average glycohemoglobin on acute myocardial infarction mortality. Of 808 consecutive diabetic patients with acute myocardial infarction, the most significant independent predictor of in-hospital mortality was the glucose concentration at admission. Baseline glycohemoglobin strongly correlated with admission hyperglycemia but did not predict mortality independently.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16018838     DOI: 10.1016/j.amjcard.2005.03.040

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  16 in total

Review 1.  Stress hyperglycaemia.

Authors:  Kathleen M Dungan; Susan S Braithwaite; Jean-Charles Preiser
Journal:  Lancet       Date:  2009-05-23       Impact factor: 79.321

Review 2.  Glycemic variability and glycemic control in the acutely ill cardiac patient.

Authors:  Jared Moore; Kathleen Dungan
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

3.  Blood glucose control and coronary heart disease.

Authors:  Cristina Bianchi; Giuseppe Penno; Roberto Miccoli; Stefano Del Prato
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

4.  No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction.

Authors:  Kathryn A Britton; Vikas Aggarwal; Anita Y Chen; Karen P Alexander; Ezra Amsterdam; Elizabeth Fraulo; Paul Muntner; Laine Thomas; Darren K McGuire; Stephen D Wiviott; Matthew T Roe; Ulrich K Schubart; Caroline S Fox
Journal:  Am Heart J       Date:  2011-04       Impact factor: 4.749

Review 5.  Impact of conditioning hyperglycemic on myocardial infarction rats: Cardiac cell survival factors.

Authors:  Christiane Malfitano; Alcione Lescano de Souza Junior; Maria Cláudia Irigoyen
Journal:  World J Cardiol       Date:  2014-06-26

6.  Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction.

Authors:  Sandra Sena; Ping Hu; Dongfang Zhang; Xiaohui Wang; Benjamin Wayment; Curtis Olsen; Erick Avelar; E Dale Abel; Sheldon E Litwin
Journal:  J Mol Cell Cardiol       Date:  2009-02-26       Impact factor: 5.000

Review 7.  Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysis.

Authors:  Yao Liu; Yan-min Yang; Jun Zhu; Hui-qiong Tan; Yan Liang; Jian-dong Li
Journal:  Cardiovasc Diabetol       Date:  2011-11-10       Impact factor: 9.951

8.  Simple clinical risk score for no-reflow prediction in patients undergoing primary Percutaneous Coronary Intervention with acute STEMI.

Authors:  Nazile Bilgin Dogan; Ebru Ozpelit; Selma Akdeniz; Muzaffer Bilgin; Nezihi Baris
Journal:  Pak J Med Sci       Date:  2015       Impact factor: 1.088

9.  Impact of admission blood glucose levels on prognosis of elderly patients with ST elevation myocardial infarction treated by primary percutaneous coronary intervention.

Authors:  Ahmet Ekmekci; Mahmut Uluganyan; Fatif Tufan; Huseyin Uyarel; Gurkan Karaca; Seref Kul; Barış Gungor; Gokhan Ertas; Betul Erer; Nurten Sayar; Mehmet Gul; Mehmet Eren
Journal:  J Geriatr Cardiol       Date:  2013-12       Impact factor: 3.327

10.  Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study.

Authors:  Nitin Narayan Gholap; Rajnikant Laxmishanker Mehta; Leong Ng; Melanie J Davies; Kamlesh Khunti; Iain B Squire
Journal:  BMJ Open       Date:  2012-09-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.